Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-18

Clinical Trial Update: Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/Phase III trial evaluating digital vital sign monitoring to reduce sleep interruptions and improve recovery was terminated, with results posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Sleep | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-12-18